Objective: To evaluate the effect of the growth factor activin A on the secretion of prolactin (PRL) and GH in cultured GH3 cells.
Introduction
Activin is a member of the transforming growth factor b (TGF-b) superfamily. Proteins of this superfamily exert potent growth-regulatory effects on their respective target tissues via a family of specific cell surface receptors. Activin mRNAs are expressed in a variety of tissues, including the ovary, testis, placenta, brain, bone marrow, and pituitary (1) , and activin receptor (typeIA, typeII and typeIIB) mRNA expression has been reported in the rat (2, 3) . Effects of activin on cellular proliferation and/or differentiation have also been observed in primary cultured cells and established cell lines (4) (5) (6) .
Activin was initially isolated from gonadal fluids characterized by their ability to stimulate follicle-stimulating hormone (FSH) secretion from cultured rat pituitary cells (7, 8) . Moreover, in cultured rat pituitary cells, activin inhibits basal growth hormone (GH) (7, 9, 10) , prolactin (PRL) (11) and adrenocorticotropin (7) secretion. Activin also inhibits thyrotropin-releasing hormone (TRH)-stimulated PRL secretion and GH-releasing factor (GRF)-stimulated GH secretion (12) . Activin thus plays important roles in hormone secretion from the pituitary. However, the detailed mechanisms of the regulation of each hormone by activin are not yet clear.
GH3 cells, an established cell line from rat pituitary tumor cells, secrete both PRL and GH (13) . It has been shown that GH3 cells retain their ability to respond to TRH (14) , epidermal growth factor (EGF) (15, 16) and nerve growth factor (NGF) (17) . Recent studies have demonstrated that activin receptors (typeIA, typeII and typeIIB) are present on GH3 cells (18, 19) . GH3 cells are thus a useful model with which to study the roles of activin in hormone secretion by the pituitary. In this study, we examined the effects of activin A on the production and secretion of PRL and GH in GH3 cells, in order to clarify the process of secretion of these hormones from the pituitary.
GH3 cells were plated into 24-multiwell plates (Nunc Inter Med., Denmark) (2×10 5 cells/well) and cultured in Ham's F10 medium (Gibco, Grand Island, NY, USA) with 15% horse serum and 2.5% fetal calf serum and penicillin (100mg/ml) at 37ЊC under a humidified atmosphere of 5% CO 2 and 95% O 2 . After pre-culture for 24 h, each medium was exchanged for medium with various concentrations of activin A. After incubation for various times, the medium was collected and stored at ¹40ЊC until assay. In the same fashion, GH3 cells were seeded into 6 cm dishes (Nunc) at a density of 3×10 6 / dish and incubated in culture medium with activin A (3.0 nM). After incubation for various times, cells were collected and used for RNA analysis.
Measurement of PRL and GH concentrations
PRL concentrations in culture medium were determined with a double-antibody RIA kit supplied by the National Pituitary Program, Bethesda, MD, USA. GH levels were measured with a rat GH assay system purchased from Amersham International plc, Aylesbury, Bucks, UK. Coefficients of intra-and interassay variation were less than 10% for both PRL and GH assays.
Cloning of rat PRL, GH and pit-1 cDNA
The partial cDNAs corresponding to rat PRL (434bp), GH (439bp) and the pituitary-specific transcription factor pit-1 (662bp) were subcloned into vectors (pBluescript KS-, Stratagene, La Jolla, CA, USA) by RT-PCR. RT-PCR was carried out with rat pituitary mRNA with the following sense primers and antisense primers: GH sense primer 5 0 -TCGAGCGTGCCTACATTCC-3 0 , GH antisense primer 5 0 -TTGAGCAGAGC GTCATCG-3 0 , PRL sense primer 5 0 -TTGACCGTGTGGTCATGC-3 0 , PRL antisense primer 5 0 -GGATTCTTCATCAACTCCTTGC-3 0 , pit-1 sense primer 5 0 -CTGAGAATGCACCACAGTGC-3 0 and pit-1 antisense primer 5 0 -ATGATCTCCTGCGAAGAAGG-3 0 . Each inserted cDNA was confirmed to correspond to rat PRL, GH or pit-1 by a DNA sequencing method.
RNA extraction and Northern blot analysis
Total RNA was extracted from cultured cells by the acid guanidinium thiocyanate-phenol-chloroform method (20) . Each total RNA (4mg) was electrophoresed in 1% agarose gel, and transferred to nylon membrane (Hybond-N; Amersham International plc). Prehybridization was performed for 2 h at 65ЊC in hybridization buffer (5 × SSC, 50% formamide, 5 × Denhardt's solution, 0.5% sodium dodecyl sulfate (SDS), and 0.02mg/ml denatured sonicated salmon sperm DNA (Sigma Chemical Co, St Louis, MO, USA). The membranes were hybridized overnight at 65ЊC in exchanged hybridization buffer with [ 32 P]-labeled DNA probe corresponding to rat PRL, GH or pit-1 cDNA. Probes were obtained with a random primer labeling kit (Rediprime; Amersham International plc) with rat PRL, GH and pit-1 cDNA. After hybridization with each probe, the membranes were washed twice with 2 × SSC plus 0.1% SDS at 65ЊC for 1 h. After crosslinking by u.v. light, autoradiography was performed at -80ЊC for 60 h. The membranes were then exposed to imaging plates (Fuji Photo Film Co. Ltd, Tokyo, Japan) for 12-24 h at room temperature. The relative amounts of the respective mRNAs were detected and 
Data analysis
Results are presented as meansϮS.E.M. The dose responses for activin addition were determined using ANOVA. For comparison between the two groups, Student's t-test was used. Findings of P<0.05 were considered significant.
Results

Effect of activin A on PRL secretion
Activin A inhibited basal PRL secretion from GH3 cells in a dose-dependent manner (Fig. 1A) . PRL concentration in culture medium significantly decreased with the addition of 0.3nM activin A, and reached 53.2% of the control level with 3nM activin. The significant inhibitory effect of activin A (3nM) on PRL secretion was observed in culture from 12 to 48 h (Fig. 1B) . Figure 2 shows the effect of activin A on PRL mRNA levels in GH3 cells determined by Northern blot analysis. The addition of 3 nM activin A suppressed the expression of PRL mRNA at 12 h and 24h, and maximum suppression (33.8% of control) was observed at 24 h. However, this inhibitory effect was no longer present at 48h, at which time the expression of PRL mRNA had returned to control level.
Effect of activin A on GH secretion
Activin A stimulated basal GH secretion from GH3 cells in a dose-dependent manner (Fig. 3A) . GH concentration in culture medium significantly increased with the addition of 3nM activin A (157.6% of control). A stimulatory effect of activin A on GH secretion was observed in culture for 48 h (Fig. 3B) . Figure 4 shows the effect of activin A on GH mRNA levels in GH3 cells determined by Northern blot analysis. Major bands corresponding to GH RNA species of 2.3 and 1.0 kb were found. The 1.0 kb species is a mature GH mRNA, and the 2.3 kb species is possibly a GH precursor RNA. The addition of 3nM activin A enhanced the expression of GH mRNA, and a significant increase in this expression (183.6% of control) was observed at 24 h. However, this stimulatory effect on mRNA tended to decline at 48 h.
Effect of activin A on expression of pit-1 mRNA
Pit-1 is a pituitary-specific transcription factor regulating the expression of PRL and GH genes. To determine the mechanism of the effect of activin A on PRL and GH secretion from GH3 cells, the effect of activin A on the expression of pit-1 mRNA in GH3 cells was examined.
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Discussion
In the present study, we demonstrated that activin A stimulated basal GH secretion and inhibited basal PRL secretion in GH3 cells via modulation of the transcription of the GH and PRL genes. Using a rat pituitary monolayer culture system, Billestrup et al. (10) reported that no reduction in GH biosynthesis was observed after 6-h treatment with activin, but that by 24 h GH biosynthesis was clearly inhibited. In our time-course studies, a significant effect of activin on PRL mRNA and GH mRNA levels also appeared at 24 h after the start of incubation. In addition, by 48h, both mRNA levels tended to return to time 0 mRNA levels. The decline of the effect of activin on PRL and GH transcription suggests the existence of a negative regulatory system in GH3 cells. It has been suggested that, in the pituitary, activin plays an autocrine or paracrine role through interaction with follistatin, which has been demonstrated to function as a negative regulator of activin as a result of its ability to bind activin.
Pit-1, a tissue-specific transcription factor, plays an important role in the transcription of the PRL and GH genes in pituitary cells. MacCormick et al. (21) and Supowit et al. (22) demonstrated that repression of both GH and PRL syntheses by activin in somatic cell hybrids between GH3 cells and mouse LB82 fibroblasts occurred as a result of the suppression of pit-1 expression. However, TGF-b was found to inhibit transcription of the PRL gene in GH3 cells, but not that of the GH gene, through a mechanism independent of pit-1 gene expression (23) . We also found that pit-1 gene transcript levels in GH3 cells were not significantly affected by activin. These data do not address the possibility of activin-induced post-translational modifications of the pit-1 protein and interactions with the promoter. Gaddy-Kurten & Vale (24) demonstrated that activin decreased GH expression in MtTW15 cells through multilevel regulation of pit-1, involving not only a decrease in pit-1 DNA-binding activity but also a decrease in the stability and synthesis of pit-1.
In a pituitary monolayer culture system, activin has been found to be a negative regulator of pituitary somatotrophs and lactotrophs (7, (9) (10) (11) . In our study, GH3 cells, which were derived from rat pituitary tumor cells, exhibited a paradoxical GH response to activin. Daniels et al. (25) reported that activin significantly increased basal GH secretion from cells of two of six human somatotrophinomas in vitro. Similar heterogeneous responses to activin were described in studies of FSH release by human gonadotropin-secreting pituitary tumor cells in vitro (26) . These findings suggest that inconsistent and paradoxical responses to activin may also occur in some tumor cells.
GH3 cells are an established cell line which may be related to the bipotential somatomammotroph from which both somatotroph and mammotroph cells derive. It has been reported that differentiation of GH3 cells into mammotroph cells is induced by NGF (17) and EGF (16) . In contrast, it has been reported, based on results of fluorescence-activated cell sorting that GRF promotes the differentiation of GH3 cells into somatotroph-like phenotypes (17) . The present findings that synthesis of PRL was inhibited and synthesis of GH was stimulated by activin suggest the possibility that differentiation of the GH3 cells into somatotrophlike cells may occur.
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Figure 5
The effect of activin A on expression of pit-1 mRNA in GH3 cells. Hybridization studies of pit-1 mRNA revealed three bands, one major band and two minor bands. The major band was 2.5 kb, and the minor bands were 4.1 and 1.6 kb. The addition of 3 nM activin A had no significant effect on these bands.
